Home/STAAR Surgical/Dr. Gary M. Wörtz

DG

Dr. Gary M. Wörtz

Chief Medical Officer

Therapeutic Areas

Ophthalmology Refractive Surgery

STAAR Surgical Pipeline

Drug	Indication	Phase
EVO ICL / EVO+ ICL	Myopia & Myopia with Astigmatism	Commercial
Hyperopic ICL	Hyperopia (Farsightedness)	Commercial (Limited)
Presbyopia-Correcting ICL	Presbyopia	Research & Development

Leadership Team at STAAR Surgical

President and Chief Executive Officer

Patrick F. Williams

Chief Financial Officer

A. John Barnhart

Chief Operating Officer

Keith A. Holliday

SVP, General Counsel & Corporate Secretary

View full STAAR Surgical profile